A highly sensitive blood test detected disease-causing antibodies in a case of myasthenia gravis (MG) believed to be induced by COVID-19. The case underscores the importance of such diagnostic tools to detect disease markers that may be missed by the current approach in diagnosing…
Combination therapy of rituximab and plasma exchange reduced disease severity in nine patients with refractory myasthenia gravis, a case series reports. The case series, “Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis and rituximab: A case series of nine patients and…
Immune B-cells originating in the thymus continue to circulate in the blood after thymectomy, causing a diminished clinical response to treatment in people with myasthenia gravis (MG), a study has found. In a commentary…
Local injections of the corticosteroid dexamethasone alleviated symptoms and resulted in complete remission in most patients with ocular myasthenia gravis, a small clinical trial has shown. Compared to systemic treatments, local injections treated symptoms faster, reduced side effects, and increased remission rate.
Women with myasthenia gravis (MG) have a diminished quality of life compared with male patients, and are particularly affected by the number of additional diseases (comorbidities) they experience, a new study from China reports. They also have a less active lifestyle, which may reveal…
Get regular updates to your inbox.